Related Experiment Video
Updated: Mar 23, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
14.5K
Andexanet: Effectively Reversing Anticoagulation.
Giuseppe Lippi1, Fabian Sanchis-Gomar2, Emmanuel J Favaloro3
1Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Trends in Pharmacological Sciences
|April 7, 2016
Summary
Reversing direct oral anticoagulants remains difficult. Andexanet, a factor Xa inhibitor reversal agent, shows promise in counteracting anticoagulant effects, offering a potential solution for managing bleeding risks.
Area of Science:
- Pharmacology
- Hematology
- Drug Development
Background:
- Direct oral anticoagulants (DOACs) are widely used for anticoagulation.
- Effective reversal of DOACs is a significant clinical challenge.
Purpose of the Study:
- To evaluate andexanet as a reversal agent for DOACs.
- To understand the mechanism of andexanet in counteracting anticoagulation.
Main Methods:
- Review of emerging evidence on andexanet.
- Analysis of andexanet's interaction with factor Xa inhibitors.
Main Results:
- Andexanet competitively inhibits and counteracts the anticoagulant effect of many factor Xa inhibitors.
- Andexanet is a recombinant, inactive variant of native factor Xa.
Conclusions:
- Andexanet presents a potential strategy for reversing DOAC-induced anticoagulation.
- Further research is needed to establish its clinical efficacy and safety profile.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:29Venous Thrombosis III: Interprofessional Care
459
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459